Use of an Intrauterine Manipulator and Its Correlation With Positive Peritoneal Cytology in Early Stage Endometrial Cancers

Description

This study aims to answer whether use of a Vcare® intrauterine manipulator leads to an increased incidence of positive peritoneal cytology in patients undergoing surgical management of early stage (FIGO stage I/II) endometrial cancer.

Conditions

Endometrial Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

This study aims to answer whether use of a Vcare® intrauterine manipulator leads to an increased incidence of positive peritoneal cytology in patients undergoing surgical management of early stage (FIGO stage I/II) endometrial cancer.

Use of an Intrauterine Manipulator and Its Correlation With Positive Peritoneal Cytology in Early Stage Endometrial Cancers

Use of an Intrauterine Manipulator and Its Correlation With Positive Peritoneal Cytology in Early Stage Endometrial Cancers

Condition
Endometrial Cancer
Intervention / Treatment

-

Contacts and Locations

York

Wellspan Health, York, Pennsylvania, United States, 17403

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Subjects age 18 or older able to give informed consent
  • * Biopsy diagnosed endometrial cancer (including endometrioid, serous, mucinous and clear cell histologies)
  • * Planned standard of care surgical management of early stage endometrial cancer
  • * No clinical evidence of disseminated intraperitoneal disease
  • * Final pathology does not reflect diagnosis of endometrial cancer (including endometrioid, serous, mucinous, and clear cell histology)
  • * Evidence of disseminated intraperitoneal disease
  • * Subject is not a surgical candidate
  • * Subject elects for fertility sparing or non-operative management
  • * Subject is unable to provide informed consent

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

WellSpan Health,

Eav Lim, DO, PRINCIPAL_INVESTIGATOR, WellSpan Health

Study Record Dates

2024-06-30